Sameh Saber

3.1k citations

118 papers · 2.1k indexed · h-index 31

Impact in

Hepatology top 5%
- Liver physiology and pathology
Pharmaceutical Science top 5%

Papers in ⓘ

Hepatology 19
- Liver physiology and pathology 10
Geriatrics and Gerontology 7
- Sirtuins and Resveratrol in Medicine 7

Co-authors: Eman El‐Ahwany (15 shared papers)Galal Yahya (16 shared papers)Mahmoud E. Youssef (21 shared papers)Simona Cavalu (20 shared papers)Walied Abdo (4 shared papers)Noha A. Amin (12 shared papers)Amal M. H. Ghanim (3 shared papers)Ahmed Shata (13 shared papers)
Journals: Biomedicine & Pharmacotherapy (9 papers)Frontiers in Pharmacology (9 papers)International Immunopharmacology (8 papers)European Journal of Pharmaceutical Sciences (7 papers)Pharmaceuticals (6 papers)
Partner nations: Egypt Saudi Arabia Romania

In The Last Decade

Sameh Saber

108 papers receiving 2.1k citations

Peers

Countries citing papers authored by Sameh Saber

Since Specialization

Citations

This map shows the geographic impact of Sameh Saber's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sameh Saber with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sameh Saber more than expected).

Fields of papers citing papers by Sameh Saber

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sameh Saber. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sameh Saber. The network helps show where Sameh Saber may publish in the future.

Co-authors

The 25 scholars most cited alongside Sameh Saber, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Sameh Saber Line = papers co-authored together Sameh Saber links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 118 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Olmesartan ameliorates chemically-induced ulcerative colitis in rats via modulating NFκB and Nrf-2/HO-1 signaling crosstalk Toxicology and Applied Pharmacology ·Sameh Saber, Rania M. Khalil, Walied Abdo, Doaa Nassif, Eman El‐Ahwany	2018	142
2	Deferoxamine-loaded transfersomes accelerates healing of pressure ulcers in streptozotocin-induced diabetic rats Journal of Drug Delivery Science and Technology ·Sanaa A. El‐Gizawy, A. Nouh, Sameh Saber, Ahmed Y. Kira	2020	65
3	The dynamic interplay between AMPK/NFκB signaling and NLRP3 is a new therapeutic target in inflammation: Emerging role of dapagliflozin in overcoming lipopolysaccharide-mediated lung injury Biomedicine & Pharmacotherapy ·Eslam E. Abd El-Fattah, Sameh Saber, Ahmed A.E. Mourad, Eman El‐Ahwany, Noha A. Amin, Simona Cavalu, Galal Yahya, Ahmed S. Saad, Mansour Alsharidah, Ahmed Shata, Haidy M. Sami, Mohamed M.Y. Kaddah, Amal M. H. Ghanim	2022	60
4	Novel complementary coloprotective effects of metformin and MCC950 by modulating HSP90/NLRP3 interaction and inducing autophagy in rats Inflammopharmacology ·Sameh Saber, Eman M. Abd El-Kader	2020	56
5	A Novel Combination Therapy Using Rosuvastatin and Lactobacillus Combats Dextran Sodium Sulfate-Induced Colitis in High-Fat Diet-Fed Rats by Targeting the TXNIP/NLRP3 Interaction and Influencing Gut Microbiome Composition Pharmaceuticals ·Sameh Saber, Eslam E. Abd El-Fattah, Galal Yahya, Naglaa A. Gobba, Abdalkareem Omar Maghmomeh, Ahmed E. Khodir, Ahmed A.E. Mourad, Ahmed S. Saad, Hager G. Mohammed, Nehal A. Nouh, Ahmed Shata, Noha A. Amin, Magdy Abou El-Rous, Samuel Girgis, Eman El‐Ahwany, Eman M. Khalaf, Attalla F. El‐kott, Ahmed M. El-Baz	2021	55
6	BBG enhances OLT1177-induced NLRP3 inflammasome inactivation by targeting P2X7R/NLRP3 and MyD88/NF-κB signaling in DSS-induced colitis in rats Life Sciences ·Sameh Saber, Mahmoud E. Youssef, Hossam Sharaf, Noha A. Amin, Ruwyda El-Shedody, Farah H. Aboutouk, Yumna Abd El-Galeel, Amr El-Hefnawy, Dina Shabaka, Arwa Khalifa, Renad Saleh, Donya Osama, Ghada El-Zoghby, Naglaa A. Gobba	2021	53
7	Combination of Vitamin C and Curcumin Safeguards Against Methotrexate-Induced Acute Liver Injury in Mice by Synergistic Antioxidant Effects Frontiers in Medicine ·Dhekra Hasan Khudhair, Ali I. Al‐Gareeb, Hayder M. Al‐kuraishy, Aya H. El-Kadem, Engy Elekhnawy, Walaa A. Negm, Sameh Saber, Simona Cavalu, Adrian Tirla, Saqer S. Alotaibi, Gaber El‐Saber Batiha	2022	51
8	Novel complementary antitumour effects of celastrol and metformin by targeting IκBκB, apoptosis and NLRP3 inflammasome activation in diethylnitrosamine-induced murine hepatocarcinogenesis Cancer Chemotherapy and Pharmacology ·Sameh Saber, Amal M. H. Ghanim, Eman El‐Ahwany, Eman M. Abd El-Kader	2020	48
9	Unlocking the Full Potential of SGLT2 Inhibitors: Expanding Applications beyond Glycemic Control International Journal of Molecular Sciences ·Mahmoud E. Youssef, Galal Yahya, Mihaela Simona Popoviciu, Simona Cavalu, Marwa A. Abdel-Dayem, Sameh Saber	2023	47
10	Mebendazole augments sensitivity to sorafenib by targeting MAPK and BCL-2 signalling in n-nitrosodiethylamine-induced murine hepatocellular carcinoma Scientific Reports ·Nancy S. Younis, Amal M. H. Ghanim, Sameh Saber	2019	47
11	Vildagliptin, a DPP-4 inhibitor, attenuates carbon tetrachloride-induced liver fibrosis by targeting ERK1/2, p38α, and NF-κB signaling Toxicology and Applied Pharmacology ·Rania M. Khalil, Ahmed Shata, Eman M. Abd El-Kader, Hossam Sharaf, Walied Abdo, Noha A. Amin, Sameh Saber	2020	46
12	Perindopril, fosinopril and losartan inhibited the progression of diethylnitrosamine-induced hepatocellular carcinoma in mice via the inactivation of nuclear transcription factor kappa-B Toxicology Letters ·Sameh Saber, Amr A. A. Mahmoud, Reham M. Goda, Noha Helal, Eman El‐Ahwany, Rasha H. Abdel‐Ghany	2018	45
13	Dapagliflozin, an SGLT2 inhibitor, ameliorates acetic acid-induced colitis in rats by targeting NFκB/AMPK/NLRP3 axis Inflammopharmacology ·Magdy Abou El-Rous, Sameh Saber, Eman M. Raafat, Amany A.E. Ahmed	2021	44
14	Empagliflozin adjunct with metformin for the inhibition of hepatocellular carcinoma progression: Emerging approach for new application Biomedicine & Pharmacotherapy ·A. M. Abdelhamid, Sameh Saber, Mahmoud E. Youssef, Ahmed Gaafar Ahmed Gaafar, Hanan Eissa, Marwa A. Abdel-Dayem, Mohammed Alqarni, Gaber El‐Saber Batiha, Ahmad J. Obaidullah, Mohamed Awad Shahien, Eman El‐Ahwany, Noha A. Amin, Mohamed Ali Etman, Mohamed M.Y. Kaddah, Eslam E. Abd El-Fattah	2021	43
15	Celastrol augments sensitivity of NLRP3 to CP-456773 by modulating HSP-90 and inducing autophagy in dextran sodium sulphate-induced colitis in rats Toxicology and Applied Pharmacology ·Sameh Saber, Eman M. Abd El-Kader, Hossam Sharaf, Rewan El-Shamy, Baraah El-Saeed, Asmaa Mostafa, Dalia Ezzat, Ahmed Shata	2020	42
16	Interference With the AMPKα/mTOR/NLRP3 Signaling and the IL-23/IL-17 Axis Effectively Protects Against the Dextran Sulfate Sodium Intoxication in Rats: A New Paradigm in Empagliflozin and Metformin Reprofiling for the Management of Ulcerative Colitis Frontiers in Pharmacology ·Mahmoud E. Youssef, Eslam E. Abd El-Fattah, A. M. Abdelhamid, Hanan Eissa, Eman El‐Ahwany, Noha A. Amin, ‏Helal F. Hetta, Mohamed H. Mahmoud, Gaber El‐Saber Batiha, Naglaa A. Gobba, Ahmed Gaafar Ahmed Gaafar, Sameh Saber	2021	42
17	In vitro and in vivo evaluation of cubosomal nanoparticles as an ocular delivery system for fluconazole in treatment of keratomycosis Drug Delivery and Translational Research ·Mohamed Nasr, Mohammed Teiama, Aliaa Ismail, A. Ebada, Sameh Saber	2020	42
18	Novel Potent and Selective DPP-4 Inhibitors: Design, Synthesis and Molecular Docking Study of Dihydropyrimidine Phthalimide Hybrids Pharmaceuticals ·Ahmed A.E. Mourad, Ahmed E. Khodir, Sameh Saber, Mai A.E. Mourad	2021	41
19	Advances in understanding cisplatin-induced toxicity: Molecular mechanisms and protective strategies European Journal of Pharmaceutical Sciences ·Elsayed A. Elmorsy, Sameh Saber, Rabab S. Hamad, Mustafa Ahmed Abdel‐Reheim, Attalla F. El‐kott, Mohammed A. AlShehri, Kareem Morsy, Salama A. Salama, Mahmoud E. Youssef	2024	40
20	Telmisartan ameliorates dextran sodium sulfate-induced colitis in rats by modulating NF-κB signalling in the context of PPARγ agonistic activity Archives of Biochemistry and Biophysics ·Sameh Saber, Mohamed Basuony, Abdelrahman S. Eldin	2019	40

About Sameh Saber

Sameh Saber is a scholar working on Hepatology, Geriatrics and Gerontology, Pharmacology, Cancer Research and Molecular Biology, having authored 118 papers that have together received 2.1k indexed citations. Recurring topics across this work include Inflammasome and immune disorders (13 papers), Liver physiology and pathology (10 papers), Liver Disease Diagnosis and Treatment (10 papers), Metabolism, Diabetes, and Cancer (7 papers), Sirtuins and Resveratrol in Medicine (7 papers), Drug-Induced Hepatotoxicity and Protection (7 papers), Heat shock proteins research (7 papers) and Autophagy in Disease and Therapy (6 papers). The work is most often cited by research in Hepatology (168 citations), Pharmaceutical Science (99 citations), Pharmacology (142 citations), Cancer Research (216 citations) and Geriatrics and Gerontology (56 citations). Sameh Saber has collaborated with scholars based in Egypt, Saudi Arabia and Romania. Frequent co-authors include Eman El‐Ahwany, Galal Yahya, Mahmoud E. Youssef, Simona Cavalu, Walied Abdo, Noha A. Amin, Amal M. H. Ghanim, Ahmed Shata, Mustafa Ahmed Abdel‐Reheim and Ahmed A.E. Mourad. Their work appears in journals such as Biomedicine & Pharmacotherapy, Frontiers in Pharmacology, International Immunopharmacology, European Journal of Pharmaceutical Sciences and Pharmaceuticals.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact